STOCK TITAN

Itron Inc Form 4 Filings

ITRI NASDAQ

Every Form 4 that Itron Inc (ITRI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ITRI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ITRI filings page.

Rhea-AI Summary

Lande Jerome J. reported acquisition or exercise transactions in this Form 4 filing.

ITRON, INC. director Jerome J. Lande received a grant of 580 shares of common stock on April 1, 2026 as part of the quarterly equity compensation paid to independent members of the board for their annual board service. Following this award, he directly holds 10,144 common shares.

Rhea-AI Summary

JAEHNERT FRANK M reported acquisition or exercise transactions in this Form 4 filing.

Itron, Inc. director Frank M. Jaehnert received a grant of 580 shares of common stock as part of his board compensation. The award was made at a stated price of $0.00 per share, reflecting a non-cash stock grant rather than an open-market purchase. Following this grant, he directly holds 22,497 shares of Itron common stock. According to the disclosure, Mr. Jaehnert deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, making this a routine, compensation-related equity award for an independent board member.

Rhea-AI Summary

Drury Scott D. reported acquisition or exercise transactions in this Form 4 filing.

Itron, Inc. director Scott D. Drury received a grant of 580 shares of Common Stock as part of his quarterly board compensation. The shares were awarded at no cash cost per share and are tied to his service as an independent board member. Following this grant, his direct holdings increased to 1,723 shares of Itron common stock. According to the disclosure, Drury deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, so the award will be delivered on a deferred basis rather than immediately.

Rhea-AI Summary

Itron, Inc. reported that SVP & CFO Joan S. Hooper disposed of 3,533 shares of common stock in an automatic transaction on February 26, 2026. The shares were sold at an average price of $95.9209 each to cover tax withholding obligations from the vesting of a restricted stock unit award. After this tax-related sale, Hooper beneficially owns 118,275 shares of Itron common stock directly.

Rhea-AI Summary

Itron, Inc. senior vice president of Outcomes Donald L. Reeves III reported selling a total of 519 shares of Itron common stock in open-market transactions. The sales occurred on February 25, 2026 at a price of $97.84 per share under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. After these trades, Reeves directly holds 29,951 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. senior vice president and general counsel Christopher E. Ware reported an automatic disposition of common stock tied to equity compensation. On this Form 4, 348 shares of common stock were sold in an open-market transaction at a price of $94.8147 per share to cover tax withholding obligations arising from the vesting of a restricted stock unit award. After this tax-related sale, Ware directly holds 30,695 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president Donald L. Reeves III reported an automatic sale of 544 shares of common stock. The shares were sold in an open-market transaction at an average price of $94.8147 per share on February 24, 2026, to cover tax withholding obligations tied to the vesting of a restricted stock unit award. After this sale, he directly holds 30,470 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. executive David Marshall Wright, VP, Corporate Controller and Chief Accounting Officer, had 188 shares of common stock automatically sold on February 24, 2026 to cover tax withholding from a restricted stock unit vesting at an average price of $94.8147 per share. Following this tax-related sale, he beneficially owns 8,936 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president of HR Laurie Ann Pulatie-Hahn reported an automatic sale of common stock tied to equity compensation. On this transaction date, 176 shares of common stock were sold in an open-market transaction at a weighted price of $94.8147 per share to cover tax withholding obligations from a vested restricted stock unit award. After this tax-related sale, she continued to hold 32,774 shares of Itron common stock directly.

Rhea-AI Summary

ITRON, INC. senior vice president Patrick Justin K reported an automatic sale of common stock tied to equity compensation. On the transaction date, 385 shares were sold in an open-market transaction at an average price of about $94.81 per share to cover tax withholding obligations from a restricted stock unit vesting. After this tax-related sale, he continued to hold 33,131 shares of Itron common stock directly.

Rhea-AI Summary

Itron, Inc. President & CEO Thomas Deitrich reported an automatic sale of 1,772 shares of common stock on February 24, 2026, at an average price of $94.8147 per share. According to the footnote, these shares were sold to cover tax withholding obligations from a restricted stock unit vesting. After this transaction, he directly holds 370,301 shares and indirectly holds 25,000 shares through a trust.

Rhea-AI Summary

ITRON, INC. senior vice president John F. Marcolini reported an automatic sale of 560 shares of common stock to cover tax withholding on a restricted stock unit vesting. The shares were sold at an average price of $94.8147 per share, leaving him with 25,278 shares directly owned.

Rhea-AI Summary

ITRON, INC. SVP & CFO Joan S. Hooper reported an automatic sale of 962 shares of common stock. The shares were sold on February 24, 2026 at an average price of $94.8147 per share to cover tax withholding obligations tied to the vesting of a restricted stock unit award.

After this tax-related sale, Hooper directly owns 121,808 shares of Itron common stock. The transaction was reported as an open-market sale but is described as being solely for tax withholding purposes rather than a discretionary share sale.

Rhea-AI Summary

ITRON, INC. senior vice president Donald L. Reeves III reported an open-market sale of 1,055 shares of common stock at an average price of $96.25 per share on February 23, 2026. The transaction was executed under a Rule 10b5-1 trading plan adopted on September 11, 2025, and he held 31,014 shares afterward.

Rhea-AI Summary

Itron, Inc. executive David Marshall Wright, VP, Corp. Controller & CAO, reported an automatic sale of common stock tied to equity compensation. On February 20, 2026, 264 shares of common stock were sold at $100.1664 per share to cover tax withholding obligations from a restricted stock unit vesting. After this tax-related sale, Wright directly held 9,124 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. senior vice president Donald L. Reeves III reported an automatic sale of common stock tied to tax withholding. On the transaction date, he sold 1,071 shares of common stock in an open-market transaction at an average price of $100.1664 per share. According to the filing, the shares were sold to cover tax withholding obligations from the vesting of a restricted stock unit award, rather than as a discretionary sale. After this transaction, Reeves beneficially owned 32,069 shares of Itron common stock directly.

Rhea-AI Summary

ITRON, INC. executive Christopher E. Ware, SVP, General Counsel and Corporate Secretary, reported an automatic disposition of common stock tied to equity compensation. On this Form 4, 763 shares of common stock were sold at an average price of $100.1664 per share to cover tax withholding obligations from the vesting of a restricted stock unit award. After this withholding-related sale, Ware directly holds 31,043 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. senior vice president of HR Laurie Ann Pulatie-Hahn reported an automatic sale of common stock tied to tax withholding. On this Form 4, 729 shares were sold on the open market at an average price of $100.1664 per share to cover taxes from a restricted stock unit vesting. After this transaction, she directly owns 32,950 shares of Itron common stock. This type of transaction reflects tax-related share withholding rather than a discretionary share sale.

Rhea-AI Summary

Itron, Inc. SVP & CFO Joan S. Hooper reported an open-market sale of 1,426 shares of common stock on February 20, 2026 at an average price of $100.1664 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations tied to a restricted stock unit vesting. After this transaction, she directly owned 122,770 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president of Networked Solutions John F. Marcolini reported an open-market sale of 1,074 shares of common stock at an average price of $100.1664 per share on February 20, 2026. According to the disclosure, these shares were automatically sold to cover tax withholding obligations arising from the vesting of a restricted stock unit award. After this tax-related sale, Marcolini directly owns 25,838 shares of Itron common stock.

Rhea-AI Summary

ITRON, INC. President & CEO Thomas Deitrich reported an automatic sale of common stock tied to equity compensation. On February 20, 2026, 3,061 shares were sold at an average price of $100.1664 per share to cover tax withholding obligations from the vesting of a restricted stock unit award. After this transaction, he held 372,073 shares directly and 25,000 shares indirectly through a trust.

Rhea-AI Summary

Itron, Inc. senior vice president Patrick Justin K reported an open-market sale of 828 shares of common stock at an average price of $100.1664 per share. According to the filing, these shares were automatically sold to cover tax withholding from a restricted stock unit vesting, and he now directly holds 33,516 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. President & CEO Thomas Deitrich reported a sale of 56,095 shares of common stock on February 19, 2026. The shares were automatically sold to cover tax withholding obligations tied to the vesting of a performance-based restricted stock unit award, according to the footnote.

These shares were sold at an average price of $99.5385 per share. After this tax-related sale, Deitrich directly holds 375,134 shares of Itron common stock and indirectly holds 25,000 shares through a trust.

Rhea-AI Summary

Itron, Inc. SVP & CFO Joan S. Hooper reported an automatic sale of 15,293 shares of common stock at an average price of about $99.54 per share. According to the footnote, the shares were sold solely to cover tax withholding tied to a vested performance-based restricted stock unit award. After this transaction, she holds 124,196 shares directly.

Rhea-AI Summary

ITRON, INC. executive John F. Marcolini, SVP of Networked Solutions, reported an automatic sale of 6,948 shares of common stock on February 19, 2026. The shares were sold in an open-market transaction at $99.5385 per share to cover tax withholding obligations tied to the vesting of a performance-based restricted stock unit award. After this transaction, Marcolini directly owned 26,912 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president of Device Solutions Patrick Justin K reported an automatic sale of common stock related to equity compensation. On the reported date, 4,930 shares were sold at an average price of $99.5385 per share to cover tax withholding obligations tied to the vesting of a performance-based restricted stock unit award. After this tax-related sale, he directly owned 34,344 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior vice president of human resources Laurie Ann Pulatie-Hahn reported an automatic sale of 3,755 shares of common stock on February 19, 2026 at an average price of $99.5385 per share. The shares were sold solely to cover tax withholding on a vested performance-based restricted stock unit award, and she retained 33,679 shares afterward.

Rhea-AI Summary

ITRON, INC. senior vice president Donald L. Reeves III reported an automatic sale of common stock to cover taxes from a vesting equity award. On this Form 4, he sold 5,419 shares of common stock in an open-market transaction at an average price of $99.5385 per share. The filing notes that these shares were sold to satisfy tax withholding obligations tied to a performance-based restricted stock unit award, rather than as a discretionary sale. After this transaction, Reeves directly holds 33,140 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. senior executive Christopher E. Ware reported an automatic share sale tied to tax withholding. On this Form 4, he disposed of 4,486 shares of common stock at an average price of $99.5385 per share to cover tax obligations from a vesting performance-based restricted stock unit award. After this transaction, he directly held 31,806 Itron shares.

Rhea-AI Summary

ITRON, INC. President & CEO Thomas Deitrich reported acquiring company shares through equity compensation awards. He received 26,511 shares of common stock in a time-based award, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds vesting in equal quarterly installments over the following 24 months. He also acquired 143,730 shares earned under a performance-based restricted stock unit award tied to the 2023–2025 performance period. Following these awards, his reported direct and indirect holdings include both directly owned shares and 25,000 shares held by a trust.

Rhea-AI Summary

ITRON, INC. senior vice president and chief financial officer Joan S. Hooper reported two stock awards of common shares on February 18, 2026. She acquired 16,066 shares at no cash cost as a grant or award. Footnotes state 8,033 of these shares vested immediately, with 8,033 vesting one-third on the first anniversary of the grant date and the remaining two-thirds in equal quarterly installments over the following 24 months. She also acquired 35,977 shares at no cash cost, representing shares earned under a performance-based restricted stock unit award for the 2023–2025 performance period.

Rhea-AI Summary

ITRON, INC. senior vice president Patrick Justin K reported acquiring company stock through two equity awards. On the reported date, he received 6,527 shares at no cost as part of a grant that vests over time, with one-third vesting after one year and the remaining two-thirds vesting in equal quarterly installments over the following 24 months. He also acquired 12,365 shares earned under a performance-based restricted stock unit award tied to the 2023–2025 performance period. Following these awards, his directly held common stock position increased as reflected in the updated ownership totals.

Rhea-AI Summary

ITRON, INC. senior vice president of HR Laurie Ann Pulatie-Hahn reported acquiring common stock through two equity awards. She received 6,276 shares as a grant that vests one-third on the first anniversary of the grant date, with the remaining two-thirds vesting in equal quarterly installments over the following 24 months.

She also acquired 9,375 shares earned under a performance-based restricted stock unit award tied to the 2023–2025 performance period. The reported transactions were at no cash cost per share and increased her directly held common stock to 37,434 shares after the latest transaction.

Rhea-AI Summary

Itron, Inc. senior vice president John F. Marcolini reported acquiring company stock through equity awards rather than open-market purchases. He received 6,527 shares of common stock as a time-based award that vests one-third after one year, with the remaining two-thirds vesting quarterly over the following 24 months. He also received 13,490 shares earned under a performance-based restricted stock unit award tied to the 2023–2025 performance period, bringing his direct holdings to 33,860 shares after these transactions.

Rhea-AI Summary

ITRON, INC. senior vice president of Outcomes Donald L. Reeves III reported acquiring company common stock through equity awards, rather than open-market purchases. On February 18, 2026, he received two grants: one for 6,527 shares and another for 13,490 shares, both at a price of $0.00 per share.

One-third of one award vests on the first anniversary of the grant date, with the remaining two-thirds vesting in equal quarterly installments over the following 24 months. The other award represents shares earned under a performance-based restricted stock unit program for the 2023–2025 performance period.

Rhea-AI Summary

Itron, Inc. reported that senior vice president and general counsel Christopher E. Ware acquired common stock through equity awards. On the reported date, he received 6,276 shares as a stock award that vests over time, with one-third vesting after one year and the remaining two-thirds in equal quarterly installments over the following 24 months. He also acquired 11,242 shares earned under a performance-based restricted stock unit award tied to the 2023–2025 performance period. Both awards were recorded at a price of $0.00 per share and are held as direct ownership.

Rhea-AI Summary

Itron, Inc. reported that VP, Corporate Controller & CAO David Marshall Wright acquired 1,807 shares of common stock as a stock award on February 18, 2026. The award was granted at $0.00 per share and is subject to time-based vesting. One-third of the award vests on the first anniversary of the grant date, and the remaining two-thirds vest in equal quarterly installments over the following 24 months. After this grant, Wright directly holds 9,388 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. executive Laurie Ann Pulatie-Hahn, SVP of Human Resources, reported an open-market sale of company common stock. On 02/11/2026, she sold 142 shares of Itron common stock at $105.2648 per share. According to the filing, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award, which is a common administrative transaction rather than a discretionary sale. After this transaction, she beneficially owned 21,783 shares of Itron common stock directly.

Rhea-AI Summary

Itron, Inc. director stock activity: A member of Itron's board of directors reported receiving a grant of 220 shares of common stock on 01/02/2026 as part of the quarterly compensation that independent directors receive for board service. The shares were reported at a price of $0, reflecting that they were granted, not purchased in the market. Following this grant, the director beneficially owned 15,773 shares directly.

The filing notes that the director, Mr. Leyden, deferred receipt of 82 of these shares under Itron's Executive Deferred Compensation Plan. The amendment also corrects an earlier arithmetic error by adding 9 shares that were inadvertently omitted in a prior report.

Rhea-AI Summary

Itron, Inc. reported an amended insider filing showing a routine equity grant to a board member. On 01/02/2026, an independent director, Mr. Drury, was granted 555 shares of Itron common stock at a stated price of $0 as part of the quarterly stock compensation that independent members of the board receive for their service. After this grant, he beneficially owned 1,143 common shares in direct form.

The filing explains that Mr. Drury deferred receipt of these shares under Itron's Executive Deferred Compensation Plan, meaning the shares are credited but delivery is postponed according to the plan’s terms. The amendment clarifies that 26 shares were previously omitted due to an arithmetic error, and are now included in the reported ownership figure.

Rhea-AI Summary

Itron, Inc. reported an amended insider filing for a board member. On 01/02/2026, an independent director received a grant of 555 shares of Itron common stock as part of the quarterly equity compensation that independent members of the board receive for their service. The shares were granted at a stated price of $0, reflecting that this was board compensation rather than an open‑market purchase.

Following this grant and the correction, the director beneficially owns 9,564 shares of Itron common stock. The amendment explains that 26 shares were previously omitted due to an arithmetic error and are now included in the reported holdings.

Rhea-AI Summary

Itron, Inc. reported that one of its directors received a grant of 555 shares of common stock on 01/02/2026 as part of the quarterly equity compensation paid to independent board members. The shares were issued at a stated price of $0, reflecting a compensatory award rather than an open-market purchase.

The amended filing corrects a prior arithmetic error by adding 26 shares that were previously omitted. Following this correction and the reported grant, the director now beneficially owns 5,623 shares of Itron common stock in direct ownership.

Rhea-AI Summary

Itron, Inc. reported an amended insider transaction for a board member. On 01/02/2026, the director received 555 shares of common stock at a stated price of $0, reflecting the quarterly stock grant that independent directors receive as part of their annual board compensation. Following this grant, the director beneficially owned 11,318 shares directly.

The amendment clarifies that the reported holdings now include an additional 26 shares that were previously omitted due to an arithmetic error, ensuring the ownership total is accurate.

Rhea-AI Summary

Itron, Inc. reported an updated insider stock holding for one of its directors. On 01/02/2026, the director received a grant of 555 shares of common stock at a price of $0, representing the quarterly stock compensation that independent board members earn as part of their annual board service. Following this grant, the director beneficially owned 1,186 shares directly. The filing is an amendment to a prior Form 4 and clarifies that 26 shares had been inadvertently omitted earlier due to an arithmetic error.

Rhea-AI Summary

Itron, Inc. reported an amended insider transaction for a board member on a Form 4/A. On 01/02/2026, an independent director received a grant of 555 shares of common stock as part of the quarterly stock compensation for serving on the board. The filing notes these shares were deferred under Itron's Executive Deferred Compensation Plan rather than received immediately. Following this grant, the director beneficially owned 21,917 Itron shares. The amendment clarifies that 26 shares had previously been omitted due to an arithmetic error.

Rhea-AI Summary

Itron, Inc. (ITRI) reported an insider transaction by its VP, Corporate Controller & Chief Accounting Officer. On 11/24/2025, the officer sold 104 shares of common stock in a single transaction at a price of $96.5061 per share. After this transaction, the officer beneficially owns 7,581 shares directly.

According to the filing, the sale represents shares that were automatically sold to cover tax withholding obligations arising from the vesting of a restricted stock unit award, rather than a discretionary open-market sale of the officer's overall holdings.

Rhea-AI Summary

Itron, Inc. (ITRI) filed a Form 4 reporting a small insider sale by an executive officer. The company’s Senior Vice President, General Counsel and Corporate Secretary reported selling 343 shares of Itron common stock on 11/24/2025 at a price of $96.5061 per share.

According to the filing, these shares were automatically sold to cover tax withholding obligations related to the vesting of a restricted stock unit award, meaning the sale was tied to compensation rather than an open-market discretionary transaction. After this sale, the reporting person directly holds 18,774 shares of Itron common stock.

Rhea-AI Summary

Itron, Inc. (ITRI) reported an insider transaction by its President & CEO, who is also a director. On 11/24/2025, the executive sold 1,750 shares of common stock in a transaction coded "S" at a price of $96.5061 per share. According to the footnote, these shares were automatically sold to cover tax withholding obligations tied to the vesting of a restricted stock unit award, meaning the sale was associated with equity compensation rather than an open‑market liquidation.

After this transaction, the executive beneficially owned 260,988 shares of Itron common stock directly and an additional 25,000 shares indirectly through a trust, indicating a substantial remaining stake in the company.

Rhea-AI Summary

ITRON, INC. (ITRI) insider activity: A senior vice president, listed as SVP, Networked Solutions, reported a small automatic sale of company stock. On 11/24/2025, the officer sold 553 shares of common stock at a price of $96.5061 per share, leaving 13,843 shares beneficially owned directly after the transaction.

According to the explanation provided, these shares were sold automatically to cover tax withholding obligations that arose when a restricted stock unit award vested. This means the sale was tied to equity compensation rather than an open-market decision to reduce overall ownership.

Rhea-AI Summary

Itron, Inc. (ITRI) reported an insider transaction by its Senior Vice President of Device Solutions. On 11/24/2025, the executive sold 379 shares of Itron common stock in an open market transaction coded "S" at a price of $96.5061 per share. After this trade, the executive directly owned 20,382 shares of Itron common stock.

According to the explanation provided, the shares sold represent stock that was automatically sold to cover tax withholding obligations related to the vesting of a restricted stock unit award. This indicates the transaction was primarily administrative in nature rather than a discretionary sale of investment holdings.